Midostaurin
Category: CancerMidostaurin Overview
Midostaurin, sold under the brand name Rydapt, is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis. It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.[1] Contents 1 AML and MDS 2 Systemic ma...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Midostaurin
Recent Midostaurin Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Midostaurin
- Capsule: 25mg
Other drugs which contain Midostaurin or a similar ingredient: (1 result)
- RYDAPT Midostaurin